Global Life Science Microscopy Device Market - 2022-2029

Global Life Science Microscopy Device Market - 2022-2029

Market Overview

Life Science Microscopy Device Market is projected to grow at a CAGR of 7.9% during the forecast period (2022-2029).

Microscopes produce enlarged images of small objects, allowing the observer an exceedingly close view of minute structures at a scale convenient for examination and analysis. The life sciences include the study of cell biology, genetics, molecular biology, botany, microbiology, zoology, evolution, ecology, and physiology. Microscopes are significantly increasing in sectors such as science and biology. There are different types of microscopes; the four most popular types are compound, stereo, digital, and pocket or handheld microscopes. The advantages of life science microscopy devices, such as 2 and 3-dimensional measurements of an object, flexibility to increase the feasibility of varied investigations, and one-point focused images, are important factors driving the increased usage of these devices in forensic testing.

Market Dynamics

Increasing usage of life science microscopes during biology and sciences research has primarily driven the global life science microscopy market in recent years. Rapid development at all levels of life science microscopy experiments, such as improvements in sample labeling, contrast, illumination, resolution, signal detection, and data processing, have all occurred. There is every reason to expect these advances to continue in the forecast period.

Technological advancements in life science microscopy devices are expected to drive market growth.

Technological advancements in life science microscopy devices with faster performance, higher efficiency, and digital technology are expected to boost product demand over the forecast period. For instance, the new technology-based TCS SP8 FALCON, made by Leica Microsystems, will facilitate fast fluorescence lifetime imaging and fluorescence correlation spectroscopy, allowing scientists to investigate the environment of proteins in specific areas of a cell. Moreover, the increasing research and development activities in small laboratories and academic institutions and increasing government funding in medical and biological studies are the other factors driving the global microscopy device market over the forecast period.

Restraint:

The high maintenance of microscopes and lack of skilled professionals to operate them are hampering the market growth.

Industry Analysis

The life science microscopy device market provides in-depth analysis of the market based on various industry factors such as porter five forces, unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The SARS-CoV-2 (COVID-19) epidemic has become a global pandemic, resulting in a global fight against COVID-19. SARS-CoV-2 is a new coronavirus from the Coronaviridae family's sarbecovirus subgenus. Coronaviruses are enveloped viruses with a single-stranded, positive-sense RNA genome. Electron microscopy (EM), a reliable tool for identifying viruses based on their ultrastructure, was one of the first approaches employed for coronavirus identification. The Coronaviridae family's name is explained by the morphology of crown-like structures found by EM, which are recognized as widely dispersed club-shaped projections around the virus envelope, forming a crown aspect in negative staining methods. Moreover, because of its superior resolution to light microscopy, EM is a valuable tool in microbiology. EM has made major contributions to the understanding of virus structure and function, as well as to the quick detection of viruses in a variety of samples. Because of its ability to detect unknown and unanticipated species, EM has shown to be an effective tool for guiding public health response during prior epidemics. For instance, transmission electron microscopy (TEM) was extensively used to describe the morphology or the morphogenesis of SARS-CoV, MERS-CoV, or, more recently, SARS-CoV-2. In contrast, the pandemic interrupts the supply chain. Thus, from the above statements, the market got affected. However, the situation is expected to improve gradually in the forecast period.

Segment Analysis/B>

The clinical research organization segment is expected to hold the largest market share in the life science microscopy device market.

Clinical research organizations account for the highest share in the global life science microscopy device market due to the use of microscopes in drug discovery. An influx of new microscopic imaging methods and tools, including advanced imaging instruments, are considerably enhancing the application of microscopes in the drug discovery process. Moreover, Nikon offers the BioPipeline LIVE and BioPipeline PLATE high content imaging systems for high throughput and high content imaging applications in drug discovery. Both systems are built around our ECLIPSE Ti2-E motorized inverted microscope and include a robotic arm that allows for the automatic interchange and imaging of up to 44 vessels, including well plates. In addition, BioPipeline LIVE delivers comprehensive incubation coverage for long-term live cell imaging-based studies. Both technologies are well suited to high throughput screening on a large scale in research facilities. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global life science microscopy device market.

North America dominates the global microscopy device market due to technological advancements, increasing investments in drug discovery, product launches, and collaborations by the key market players are the factors the market is driven in the forecast period. For instance, the sustained investment in research and development (R&D) by PhRMA member firms has resulted in innovative medications that have transformed human health. Innovative biopharmaceutical approaches to treating patients for a wide range of diseases, including chronic and rare ailments, and meeting critical new health problems such as COVID-19, are having a favorable impact. Moreover, according to the 2022 PhRMA member annual survey, PhRMA member businesses invested $102.3 billion in R&D in 2021 alone, the greatest investment on record. In addition, according to the report, R&D will account for almost one-fifth of all revenue in 2021. Furthermore, PhRMA members' R&D spending makes for the majority of the expected $122.2 billion spent on R&D by the whole US biopharmaceutical industry in 2020. Therefore, it has increased the demand for life science microscopy devices.

Moreover, On June 7, 2022, the University of Wisconsin–Madison Department of Biochemistry hosted the grand opening of its Cryo-Electron Microscopy Research Center (CEMRC) and Midwest Center for Cryo-Electron Tomography (MCCET). The CEMRC provides access to cryo-EM instrumentation, training, and technical assistance for both UW–Madison and external researchers. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the life science microscopy device market are Olympus Corporation, Hitachi High-Technologies Corporation, Carl Zeiss Microscopy GmbH, Nikon Corporation, PicoQuant, Bruker, Jeol Ltd, CAMECA Instruments Inc, Motic, Asylum Research.

Olympus Corporation:

Overview:

Olympus Corporation is a manufacturer of optical and digital precision machinery and instruments. The company develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, endoscopes and endoscopy products to help healthcare professionals treat patients; scientific solutions such as laser scanning microscopes, industrial and biological microscope systems, and remote visual inspection products and non-destructive testing systems. It also offers biomedical materials and system development services. The company operates in the Americas, Europe, and Asia-Pacific through its subsidiaries and facilities.

Product Portfolio:

FLUOVIEW FV3000: The FLUOVIEW FV3000 family of confocal laser scanning microscopes tackles some of modern science's most demanding difficulties. The FV3000 confocal microscope, with its high sensitivity and speed required for live cell imaging and deep tissue observation, provides a wide range of imaging modalities, including macro-to-micro imaging, super-resolution microscopy, and quantitative data analysis.

The global life science microscopy device market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.